Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZNP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,914
Award facts
- Contract value 100% obligated
- $25,914.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,914.05 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials. This firm fixed-price, competitively awarded contract (no set-aside designation) was executed on January 7, 2026, with an ultimate completion date of January 8, 2026. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is a child contract under AmerisourceBergen's parent company, Cencora, Inc., and is issued under the broader DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999.999 billion through December 2031, which provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor within the federal medical procurement ecosystem, supplying a diverse portfolio of brand-name and generic medications, vaccines, and specialized medical commodities to military and veteran healthcare systems. The Ozempic delivery order reflects the company's role in providing diabetes management medications to support Defense Health Agency operations and other federal healthcare customers. As a single-award IDC holder with the DLA, AmerisourceBergen maintains a significant competitive advantage in fulfilling federal pharmaceutical requirements and demonstrates consistent capability to deliver essential medical products across multiple therapeutic domains to government healthcare institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F4ZNP?
SPE2DR26F4ZNP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F4ZNP worth?
The government has obligated $25,914 on SPE2DR26F4ZNP.
Is contract SPE2DR26F4ZNP an order under another contract?
Yes. SPE2DR26F4ZNP is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZNP competed?
The extent of competition for SPE2DR26F4ZNP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award